However, oral weight-loss medications do exist: oral Wegovy (semaglutide) was approved in late 2025, and Foundayo (orforglipron), an oral GLP-1 pill from Eli Lilly, was FDA-approved in April 2026
4 While several of these have scientific backing, the regulatory status of several herbs used to support immunity limits their use in complete and balanced dog food
For GLP-1 users, glucomannan can complement the appetite-suppressing effects of medications like semaglutide and tirzepatide by creating additional stomach volume
212 FBXO31 enhances cisplatin-induced ferroptosis in cholangiocarcinoma cells and stem cell-like cells, and the mechanism may be related to increased GPX4 ubiquitination and proteasome degradation, which could be reversed by GPX4 overexpression
That said, most published studies have used injection methods, and oral bioavailability in humans has not been clinically established
Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress